These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26516769)

  • 1. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
    Peterson SM; Pack TF; Caron MG
    PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
    Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
    Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
    J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.
    Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG
    Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of biased agonism at the dopamine D₂ receptor.
    Weichert D; Banerjee A; Hiller C; Kling RC; Hübner H; Gmeiner P
    J Med Chem; 2015 Mar; 58(6):2703-17. PubMed ID: 25734236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
    Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
    Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.
    Park SM; Chen M; Schmerberg CM; Dulman RS; Rodriguiz RM; Caron MG; Jin J; Wetsel WC
    Neuropsychopharmacology; 2016 Feb; 41(3):704-15. PubMed ID: 26129680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.
    Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects.
    Wenk D; Khan S; Ignatchenko V; Hübner H; Gmeiner P; Weikert D; Pischetsrieder M; Kislinger T
    J Proteome Res; 2023 Jan; 22(1):259-271. PubMed ID: 36508580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
    Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
    Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
    Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
    Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity.
    Montgomery D; Campbell A; Sullivan HJ; Wu C
    J Biomol Struct Dyn; 2019 Aug; 37(12):3206-3225. PubMed ID: 30124143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.
    Brust TF; Hayes MP; Roman DL; Burris KD; Watts VJ
    J Pharmacol Exp Ther; 2015 Mar; 352(3):480-93. PubMed ID: 25539635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization.
    Octeau JC; Schrader JM; Masuho I; Sharma M; Aiudi C; Chen CK; Kovoor A; Celver J
    PLoS One; 2014; 9(8):e105791. PubMed ID: 25162404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.